Shenandoah Therapeutics is a biotechnology company.
Shenandoah Therapeutics has raised $20.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Shenandoah Therapeutics's investors include Highlight Capital, Samsara BioCapital.
Shenandoah Therapeutics is headquartered in South San Francisco, United States.
Shenandoah Therapeutics is a biotechnology company.
Shenandoah Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shenandoah Therapeutics — Funding & Investors." VCBacked, June 19, 2025, https://www.vcbacked.co/company/shenandoah-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Shenandoah Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/shenandoah-therapeutics
{{cite web |title=Shenandoah Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/shenandoah-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated